Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

SMALL WORLD NETWORK MEASURES PREDICT WHITE MATTER DEGENERATION IN PATIENTS WITH EARLY-STAGE MILD COGNITIVE IMPAIRMENT.

Nir T, Jahanshad N, Jack CR, Weiner MW, Toga AW, Thompson PM; the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Proc IEEE Int Symp Biomed Imaging. 2012:1405-1408.

2.

Multiple diffusion indices reveals white matter degeneration in Alzheimer's disease and mild cognitive impairment: a tract-based spatial statistics study.

Shu N, Wang Z, Qi Z, Li K, He Y.

J Alzheimers Dis. 2011;26 Suppl 3:275-85. doi: 10.3233/JAD-2011-0024.

PMID:
21971467
3.

White matter damage of patients with Alzheimer's disease correlated with the decreased cognitive function.

Duan JH, Wang HQ, Xu J, Lin X, Chen SQ, Kang Z, Yao ZB.

Surg Radiol Anat. 2006 May;28(2):150-6. Epub 2006 Apr 14.

PMID:
16614789
4.

Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.

Fellgiebel A, Wille P, Müller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P.

Dement Geriatr Cogn Disord. 2004;18(1):101-8. Epub 2004 Apr 14.

PMID:
15087585
5.

Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study.

Teipel SJ, Meindl T, Wagner M, Stieltjes B, Reuter S, Hauenstein KH, Filippi M, Ernemann U, Reiser MF, Hampel H.

J Alzheimers Dis. 2010;22(2):507-22. doi: 10.3233/JAD-2010-100234.

PMID:
20847446
6.

When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.

Di Paola M, Di Iulio F, Cherubini A, Blundo C, Casini AR, Sancesario G, Passafiume D, Caltagirone C, Spalletta G.

Neurology. 2010 Apr 6;74(14):1136-42. doi: 10.1212/WNL.0b013e3181d7d8cb.

PMID:
20368633
7.

Evaluation of white matter damage in patients with Alzheimer's disease and in patients with mild cognitive impairment by using diffusion tensor imaging.

Ukmar M, Makuc E, Onor ML, Garbin G, Trevisiol M, Cova MA.

Radiol Med. 2008 Sep;113(6):915-22. doi: 10.1007/s11547-008-0286-1. Epub 2008 Jul 10.

PMID:
18618077
8.

White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study.

Kraus MF, Susmaras T, Caughlin BP, Walker CJ, Sweeney JA, Little DM.

Brain. 2007 Oct;130(Pt 10):2508-19. Epub 2007 Sep 14.

9.

[Assessment of axonal degeneration on Alzheimer's disease with diffusion tensor MRI].

Stahl R, Dietrich O, Teipel S, Hampel H, Reiser MF, Schoenberg SO.

Radiologe. 2003 Jul;43(7):566-75. German.

PMID:
12955221
10.

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G.

Brain. 2007 Jul;130(Pt 7):1767-76. Epub 2007 May 23.

11.

White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study.

Medina D, DeToledo-Morrell L, Urresta F, Gabrieli JD, Moseley M, Fleischman D, Bennett DA, Leurgans S, Turner DA, Stebbins GT.

Neurobiol Aging. 2006 May;27(5):663-72. Epub 2005 Jul 7.

PMID:
16005548
12.

Multiple diffusivities define white matter degeneration in amnestic mild cognitive impairment and Alzheimer's disease.

Wang PN, Chou KH, Lirng JF, Lin KN, Chen WT, Lin CP.

J Alzheimers Dis. 2012;30(2):423-37. doi: 10.3233/JAD-2012-111304.

PMID:
22430530
14.

White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging.

Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, Comi G, Filippi M.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):742-6.

15.

Diffusion-weighted MR of the brain: methodology and clinical application.

Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N.

Radiol Med. 2005 Mar;109(3):155-97. Review. English, Italian.

PMID:
15775887
16.

HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study.

Stebbins GT, Smith CA, Bartt RE, Kessler HA, Adeyemi OM, Martin E, Cox JL, Bammer R, Moseley ME.

J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):564-73.

PMID:
18193498
17.

Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.

Likitjaroen Y, Meindl T, Friese U, Wagner M, Buerger K, Hampel H, Teipel SJ.

Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):341-50. doi: 10.1007/s00406-011-0234-2. Epub 2011 Aug 5.

PMID:
21818628
18.
19.

Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI.

Zhuang L, Sachdev PS, Trollor JN, Kochan NA, Reppermund S, Brodaty H, Wen W.

Neurology. 2012 Aug 21;79(8):748-54. doi: 10.1212/WNL.0b013e3182661f4d. Epub 2012 Jul 25.

PMID:
22843270
20.

Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.

Bosch B, Arenaza-Urquijo EM, Rami L, Sala-Llonch R, Junqué C, Solé-Padullés C, Peña-Gómez C, Bargalló N, Molinuevo JL, Bartrés-Faz D.

Neurobiol Aging. 2012 Jan;33(1):61-74. doi: 10.1016/j.neurobiolaging.2010.02.004. Epub 2010 Apr 3.

PMID:
20371138
Items per page

Supplemental Content

Write to the Help Desk